CS logo
small CS logo
North Shore Diabetes and Endocrine Associates

New Hyde Park, New York, United States
Medical clinic in Manhasset Hills, New York
3003 New Hyde Park Rd, New Hyde Park, NY 11042

About North Shore Diabetes and Endocrine Associates


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Mannkind Corporation
7
Joslin Diabetes Center
2
Amgen
1
DeveloGen Israel, Ltd.
1
Eisai Inc.
1
Gan and Lee Pharmaceuticals, USA
1
Mylan Inc.
1
Novartis
1
Novartis Pharmaceuticals
1
Total Rows: 9

Clinical Trials at North Shore Diabetes and Endocrine Associates


During the past decade, North Shore Diabetes and Endocrine Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1122001100110011Started TrialsCompleted Trails20182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)
2002-10-01
2007-05-01
Terminated
100
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes
2006-02-01
2008-08-01
Completed
589
Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up
2006-02-01
2008-09-01
Completed
677
Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
2004-12-01
Completed
547
Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D)
2006-10-01
2010-12-01
Completed
277
A 2-Month Safety Follow-Up Trial
2007-05-01
2008-09-01
Completed
649
Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II
2008-11-01
Completed
638
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes
2008-11-01
2010-10-01
Completed
338

Rows per page:

1–16 of 16

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "North Shore Diabetes and Endocrine Associates" #1 sponsor was "Mannkind Corporation" with 7 trials, followed by "Joslin Diabetes Center" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "DeveloGen Israel, Ltd." with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "North Shore Diabetes and Endocrine Associates" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "Mylan GmbH" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsMannkind Corporation: 7Mannkind Corporation: 7Joslin Diabetes Center: 2Joslin Diabetes Center: 2Amgen: 1Amgen: 1DeveloGen Israel, Ltd.: 1DeveloGen Israel, Ltd.: 1Eisai Inc.: 1Eisai Inc.: 1Gan and LeePharmaceuticals, USA:1Gan and LeePharmaceuticals, USA:1Mylan Inc.: 1Mylan Inc.: 1Novartis: 1Novartis: 1Novartis Pharmaceuticals: 1Novartis Pharmaceuticals: 1

Created with Highcharts 11.1.0Top CollaboratorsNational Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 2National Institute ofDiabetes and Digestiveand Kidney Diseases(NIDDK): 2Mylan GmbH: 1Mylan GmbH: 1Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1Thrombolysis InMyocardial Infarction(TIMI) AcademicResearch Organization:1

Clinical Trials Conditions at North Shore Diabetes and Endocrine Associates


According to Clinical.Site data, the most researched conditions in "North Shore Diabetes and Endocrine Associates" are "Type 2 Diabetes" (5 trials), "Diabetes Mellitus, Type 1" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Type 1 Diabetes" (2 trials) and "Type 2 Diabetes Mellitus" (2 trials). Many other conditions were trialed in "North Shore Diabetes and Endocrine Associates" in a lesser frequency.

Clinical Trials Intervention Types at North Shore Diabetes and Endocrine Associates


Most popular intervention types in "North Shore Diabetes and Endocrine Associates" are "Drug" (15 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Technosphere Insulin Inhalation Powder" (3 trials), "Salsalate" (2 trials), "Technosphere Insulin" (2 trials) and "Technosphere® Insulin Inhalation Powder" (2 trials). Other intervention names were less common.

Clinical Trials Genders at North Shore Diabetes and Endocrine Associates


The vast majority of trials in "North Shore Diabetes and Endocrine Associates" are 16 trials for "All" genders.

Clinical Trials Status at North Shore Diabetes and Endocrine Associates


Currently, there are NaN active trials in "North Shore Diabetes and Endocrine Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in North Shore Diabetes and Endocrine Associates, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in North Shore Diabetes and Endocrine Associates, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 4Phase 2: 4Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 9Completed: 9Terminated: 3Terminated: 3Active, not recruiting: 1Active, not recruiting: 1No longer available: 1No longer available: 1Recruiting: 1Recruiting: 1Withdrawn: 1Withdrawn: 1